Gilder Gagnon Howe & Co’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
ACH
NAMA
CIP
Gilder Gagnon Howe & Co's VCYT Position: Q3 2022 in Review
Gilder Gagnon Howe & Co sold out of Veracyte (VCYT) in Q3 2022, closing a stake of 12,247 shares — an estimated $244K sold.
Gilder Gagnon Howe & Co first reported a position in VCYT in Q4 2013 and held it in 23 quarters. The position peaked at $145M in Q4 2020. 208 funds tracked by Wall St. Rank hold VCYT as of Q3 2022.
- Gilder Gagnon Howe & Co reported no remaining Veracyte position as of Q3 2022 after selling out during the quarter.
- Gilder Gagnon Howe & Co sold 12,247 Veracyte shares in Q3 2022, an estimated $244K.
- Gilder Gagnon Howe & Co first reported a position in Veracyte in Q4 2013 and held it in 23 quarters.
- Gilder Gagnon Howe & Co's Veracyte position peaked at $145M in Q4 2020.
- 208 funds tracked by Wall St. Rank held Veracyte as of Q3 2022.
Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2022, filed 14 Nov 2022.